This MedLibrary.org supplementary page on McNeil Laboratories is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
| This article may require cleanup to meet Wikipedia's quality standards. Please improve this article if you can. (December 2007) |
McNeil Laboratories is an American pharmaceutical company and a subsidiary of Johnson & Johnson.
Contents |
History
The company was founded on March 17, 1879 by 23 year old Robert McNeil, who paid US $167 for a drugstore complete with fixtures, inventory and soda fountain, as a retail pharmacy, in the Kensington section of Philadelphia, PA, USA. Robert McNeil was a graduate of the Philadelphia College of Pharmacy and Science (University of the Sciences in Philadelphia).
In 1904, McNeil's only son, Robert Lincoln McNeil, became part of the company and together they created McNeil Laboratories in 1933. The company would focus on direct marketing of prescription drugs to hospitals, pharmacists, and doctors. In 1953 McNeil Laboratories introduced Algoson, a preparation containing acetaminophen together with sodium butabarbital, a sedative. In 1955, McNeil Laboratories introduced Tylenol Elixir for children, only containing acetaminophen.
In 1959, Johnson & Johnson acquired McNeil Laboratories and a year later the company was able to sell Tylenol for the first time ever, without a prescription. In 1961 the company moved into its Fort Washington headquarters. Along with their Fort Washington plant, McNeil also has plants in Lancaster, PA and Las Piedras, Puerto Rico.
In 1977, two companies were created: McNeil Pharmaceutical and McNeil Consumer Products Company or McNeil Consumer Healthcare.
The current president of McNeil Consumer Healthcare is Ashley McEvoy.
McNeil Pharmaceutical
The focus of McNeil Pharmaceutical is to market prescription drugs. In 1993 McNeil Pharmaceutical merged with the Ortho Pharmaceutical Corporation to form Ortho-McNeil Pharmaceutical
McNeil Consumer & Specialty Pharmaceuticals
In 2001 McNeil Consumer Healthcare changed its name to McNeil Consumer & Specialty Pharmaceuticals. However, it was changed again and is now known as "McNeil Consumer Healthcare". The company markets over-the-counter and prescription pharmaceuticals including complete lines of Tylenol and Motrin IB (ibuprofen) products for adults and children. The company is located in Fort Washington, PA, and currently employs 2,600 people. Annual sales in 2004 were US $2.1 billion.
See also
External links
- McNeil Consumer Healthcare Company (History)
|
||||||||||||||||||||||
Wikipedia content modification information:
- This page was last modified on 5 October 2008, at 18:52.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "McNeil Laboratories".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.
